Approximately one-third of women who were at low atherosclerotic cardiovascular disease (ASCVD) risk had coronary artery calcium (CAC), according to a meta-analysis of five population-based cohorts.

A registry analysis found that providing bystander cardiopulmonary resuscitation (CPR) following out-of-hospital cardiac arrest was associated with an improvement in survival and neurologically favorable survival in children younger than 18 years old. However, bystander CPR only occurred in 46.5 percent of the out-of-hospital cardiac arrests.

After 76 weeks of treatment, patients with symptomatic coronary artery disease who received evolocumab plus statin therapy had a statistically significant regression of atherosclerosis compared with patients who received statins and a placebo, according to a randomized trial.

After 90 days of treatment, patients with atherosclerotic cardiovascular disease who received 300 mg of inclisiran daily had a mean low-density lipoprotein (LDL) cholesterol reduction of approximately 50 percent, according to a pre-specified interim analysis of a phase 2 randomized trial.

From 2002 to 2013, the use of statins in the U.S. increased 79.8 percent among adults who were at least 40 years old, according to a retrospective longitudinal cohort study.

Adults with a high genetic risk for coronary artery disease had a nearly 50 percent lower relative risk of coronary artery disease if they adhered to a favorable lifestyle compared with those who had an unfavorable lifestyle, according to an analysis of three prospective cohorts and a cross-sectional study.

Between 1983 and 2011, the incidence of coronary heart disease decreased by nearly 20 percent, according to an analysis of five observational cohort studies.

New guidelines from the U.S. Preventive Services Task Force (USPSTF) may increase the number of adults who are prescribed statins.